AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

RESMED INC Director's Dealing 2022

Jul 16, 2022

30071_dirs_2022-07-15_80c6434a-171a-40ae-b598-16cc39ad6a34.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2022-07-01

Reporting Person: BLAISE LUCILE (President, Sleep & RC Business)

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	6915	Direct

Footnotes

F1: Reflects beneficially owned shares as of July 1, 2022 when Ms. Blaise was appointed as an executive officer.